Search results for abx831579

Trastuzumab, Abbexa, abx831579

Trastuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ERBB2 (HER2 , Tyrosine kinase-type cell surface receptor HER2, MLN19, Metastatic lymph node gene 19 protein, ERBB2, Proto-oncogene Neu, p185erbB2, CD/antigen=CD340, Proto-oncogene c-ErbB-2, MLN 19, NEU, Receptor tyrosine-protein kinase erbB-2, NGL), for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has the potential for HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer research.